ARCHIVES

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 23 No. 01 | January 10, 1997

Download PDF Visit The Full Archive

Related Articles

Review Group Urges Increased Funding For NCI AIDS Drug Discovery Program

December 3, 1999

Study Recommends Longer Courses Of Chemotherapy For Bone Marrow Cancer

March 31, 2006

NCCS Networker Volume 2 Issue 2, Spring 1988

April 13, 1988

Minna To Direct Howard Simmons Cancer Center At Texas Southwestern; ‘Major Loss’ for NCI

March 1, 1991

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

February 21, 2003